Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preoperative HBOT in Pancreaticoduodenectomy
NCT02575014Unknown
- Sponsor
- AdventHealth
- Start
- Oct 2013
- Primary completion
- Dec 2018
- Countries
- 1
01
Overview
Randomised, open-label trial of hyperbaric oxygen therapy in periampullary adenocarcinoma, duodenal cancer, Pancreatic intraepithelial neoplasia (PanIN) and 2 more, sponsored by AdventHealth. Primary endpoint: Number of participants with hyperbaric oxygen treatment related adverse events. Status: unknown.
02
Drugs
hyperbaric oxygen therapy
03
Conditions
periampullary adenocarcinomaduodenal cancerPancreatic intraepithelial neoplasia (PanIN)intraductal papillary mucinous neoplasm (IPMN)cholangiocarcinoma (CCA)
Beyond the preview
Go deeper on NCT02575014.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02575014.